IP Library Granted Patent US 7,323,304
Granted Patent B2
US 7,323,304 · App. 10/524,544 · Granted Jan 29, 2008

Method for the immunocytological or molecular detection of disseminated tumor cells from a body fluid and kit that is suitable therefor

Assignee: Hexal Gentech ForschungsGmbH
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,323,304
App. No.
10/524,544
Granted
Jan 29, 2008
Kind
B2
Abstract

The invention relates to a method for enriching tumor cells from a body fluid, in which a cell separation medium of a specific density is overlaid with the body fluid and it is subsequently determined whether the enriched cells express an epithelial marker, for example a cytokeratin. A kit suitable for this method is likewise provided.

Claims (9)

1. A method for detecting disseminated tumor cells that express any of cytokeratins 1-20 from a body fluid, in which non-tumor cells which express at least one of cytokeratins 1-20 are separated from tumor cells which express at least one of cytokeratin 1-20, the method comprising:

a) enriching tumor cells by a cell separation medium which has a density in the range from 1.055 to 1.065 g/ml being overlaid with the body fluid and being centrifuged, thus separating cytokeratin-positive and cytokeratin-negative blood cells from one another, with the enriched tumor cells being present in the same fraction as the cytokeratin-negative blood cells; wherein the centrifugation is carried out in a vessel which is divided by a porous barrier, a filter, a sieve, or a flap into an upper and a lower compartment, the cell separation medium being introduced into the lower compartment, and the body fluid being put in the upper compartment, and wherein the porous barrier, the filter, the sieve or the flap has a thickness of 0.5-10 mm; and

b) using RT-PCR with a cytokeratin 1-20 specific primer to detect said any cytokeratin 1-20 expressing tumor cells in said enriched tumor cell fraction.

2. The method of claim 1 , wherein the porous barrier, the filter, the sieve or the flap has a porous size of 20-100 μm.

3. The method of claim 2 , wherein the porous barrier, the filter, the sieve or the flap is a hydrophobic material or is coated with a hydrophobic material.

4. The method of claim 1 , wherein the cell separation medium comprises a dye which makes the cell separation medium distinguishable in color from the overlying body fluid, and thus simplifies location of the interphase.

5. The method of claim 1 , wherein in step b) there is determination in single or combination analysis of whether the enriched cells express at least one epithelial marker from cytokeratins 1-20.

6. The method of claim 1 , wherein the porous barrier, the filter, the sieve or the flap has a thickness of 1-5 mm.

7. The method of claim 2 , wherein the porous barrier, the filter, the sieve or the flap has a porous size of 20-30 μm.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2010
From: HEXAL AKTIENGESELLSCHAFT
To: DAHM, MICHAEL W., DR.
Reel/Frame 024263/0808 →
CHANGE OF NAME Recorded Mar 15, 2010
From: HEXAL GENTECH FORSCHUNGS GMBH
To: HEXAL AKTIENGESELLSCHAFT
Reel/Frame 024079/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2005
From: DAHM, MICHAEL W.
To: HEXAL GENTECH FORSCHUNGSGMBH
Reel/Frame 015920/0776 →
Priority Claims (1)
DE 102 37 296 · Aug 14, 2002 · national
Continuity (1)
Related Publication 20060057650A1 · Mar 16, 2006